116 related articles for article (PubMed ID: 36210690)
1. Association between Serum Carcino-embryonic Antigen Levels and Micropapillary Bladder Cancer Metastasis in an Elderly Male.
Ediz C; Terzi NK; Akan S; Yilmaz O
J Coll Physicians Surg Pak; 2022 Aug; 32(8):S186-S188. PubMed ID: 36210690
[TBL] [Abstract][Full Text] [Related]
2. [Metastatic micropapillary variant of the urinary bladder: progression from low grade non-muscle invasive bladder carcinoma].
Sanjo H; Ito Y; Osaka K; Komiya A; Kobayashi K; Sakai N; Noguchi S; Kishi H
Hinyokika Kiyo; 2012 Aug; 58(8):447-51. PubMed ID: 23052272
[TBL] [Abstract][Full Text] [Related]
3. [Case report: lymph node metastasis of micropapillary bladder tumor that completely responded to radiation therapy].
Koizumi K; Irie K; Yokoyama H; Hosaka K; Takezaki T; Koyama T
Nihon Hinyokika Gakkai Zasshi; 2008 Jul; 99(5):652-5. PubMed ID: 18697472
[TBL] [Abstract][Full Text] [Related]
4. Second transurethral resection and prognosis of high-grade non-muscle invasive bladder cancer in patients not receiving bacillus Calmette-Guérin.
Angulo JC; Palou J; García-Tello A; de Fata FR; Rodríguez O; Villavicencio H
Actas Urol Esp; 2014 Apr; 38(3):164-71. PubMed ID: 24613147
[TBL] [Abstract][Full Text] [Related]
5. Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study.
Samaratunga H; Khoo K
Histopathology; 2004 Jul; 45(1):55-64. PubMed ID: 15228444
[TBL] [Abstract][Full Text] [Related]
6. Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.
Witjes WP; Witjes JA; Oosterhof GO; Debruyne MJ
Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):10-6. PubMed ID: 8727805
[TBL] [Abstract][Full Text] [Related]
7. Bacillus Calmette-Guerin therapy after the second transurethral resection significantly decreases recurrence in patients with new onset high-grade T1 bladder cancer.
Iida K; Naiki T; Kawai N; Etani T; Ando R; Ikegami Y; Okamura T; Kubota H; Okada A; Kohri K; Yasui T
BMC Urol; 2016 Feb; 16():8. PubMed ID: 26920373
[TBL] [Abstract][Full Text] [Related]
8. [A Case of Para-Aortic Lymph Node Metastasis 10 Years after Transurethral Resection for Non-Muscle Invasive Bladder Cancer].
Horibe Y; Ujike T; Fukuhara S; Fujita K; Kiuchi H; Uemura M; Imamura R; Nonomura N
Hinyokika Kiyo; 2021 Jul; 67(7):327-330. PubMed ID: 34353015
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcomes of cT1 micropapillary bladder cancer.
Willis DL; Fernandez MI; Dickstein RJ; Parikh S; Shah JB; Pisters LL; Guo CC; Henderson S; Czerniak BA; Grossman HB; Dinney CP; Kamat AM
J Urol; 2015 Apr; 193(4):1129-34. PubMed ID: 25254936
[TBL] [Abstract][Full Text] [Related]
10. Micropapillary component of urothelial carcinoma detected in transurethral resection of bladder tumor (TUR-BT) tissues: a case report.
Ohtsuki Y; Ochi K; Okada Y; Kato M; Lee GH; Furihata M
Med Mol Morphol; 2008 Jun; 41(2):113-6. PubMed ID: 18592166
[TBL] [Abstract][Full Text] [Related]
11. Is it possible to stop follow-up of patients with primary T1G3 urothelial carcinoma of the bladder managed with intravesical bacille Calmette-Guérin immunotherapy?
Golabek T; Palou J; Rodríguez O; Gaya JM; Breda A; Villavicencio H
World J Urol; 2017 Feb; 35(2):237-243. PubMed ID: 27277599
[TBL] [Abstract][Full Text] [Related]
12. EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016.
Babjuk M; Böhle A; Burger M; Capoun O; Cohen D; Compérat EM; Hernández V; Kaasinen E; Palou J; Rouprêt M; van Rhijn BWG; Shariat SF; Soukup V; Sylvester RJ; Zigeuner R
Eur Urol; 2017 Mar; 71(3):447-461. PubMed ID: 27324428
[TBL] [Abstract][Full Text] [Related]
13. Renal Tuberculosis Following Intravesical Bacillus Calmette-Guérin (BCG) Immunotherapy for the Treatment of Bladder Cancer.
Bajramovic S; Alic J; Skopljak E; Chikha A; Vesnic S; Smajilbegovic V; Aganovic D
Med Arch; 2020 Apr; 74(2):146-150. PubMed ID: 32577059
[TBL] [Abstract][Full Text] [Related]
14. [Intravesical instillation of bacillus Calmette-Guerin for superficial bladder carcinoma: study on significance of additional maintenance instillations of bacillus Calmette-Guerin].
Yabusaki N; Komatsu H; Tago K; Yamada Y; Ueno A
Nihon Hinyokika Gakkai Zasshi; 1991 Feb; 82(2):290-6. PubMed ID: 1904120
[TBL] [Abstract][Full Text] [Related]
15. Cancer Antigen 15-3 Serum Level as a Biomarker for Advanced Micropapillary Urothelial Carcinoma of the Bladder: A Case Report.
Takayama K; Narita S; Terai Y; Saito R; Habuchi T
Case Rep Oncol; 2021; 14(2):1019-1024. PubMed ID: 34326737
[TBL] [Abstract][Full Text] [Related]
16. Urinary bladder urothelial carcinoma with concurrent plasmacytoid and micropapillary differentiations: A report of two cases with an emphasis on serum carbohydrate antigen 19-9.
Makise N; Morikawa T; Takeshima Y; Fujimura T; Homma Y; Fukayama M
Pathol Int; 2015 Sep; 65(9):495-500. PubMed ID: 26044127
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for positive findings in patients with high-grade T1 bladder cancer treated with transurethral resection of bladder tumour (TUR) and bacille Calmette-Guérin therapy and the decision for a repeat TUR.
Orsola A; Cecchini L; Raventós CX; Trilla E; Planas J; Landolfi S; de Torres I; Morote J
BJU Int; 2010 Jan; 105(2):202-7. PubMed ID: 19558557
[TBL] [Abstract][Full Text] [Related]
18. The effect of restaging transurethral resection on recurrence and progression rates in patients with nonmuscle invasive bladder cancer treated with intravesical bacillus Calmette-Guérin.
Sfakianos JP; Kim PH; Hakimi AA; Herr HW
J Urol; 2014 Feb; 191(2):341-5. PubMed ID: 23973518
[TBL] [Abstract][Full Text] [Related]
19. Micropapillary morphology is an indicator of poor prognosis in patients with urothelial carcinoma treated with transurethral resection and radiochemotherapy.
Bertz S; Wach S; Taubert H; Merten R; Krause FS; Schick S; Ott OJ; Weigert E; Dworak O; Rödel C; Fietkau R; Wullich B; Keck B; Hartmann A
Virchows Arch; 2016 Sep; 469(3):339-44. PubMed ID: 27392930
[TBL] [Abstract][Full Text] [Related]
20. Recurrence and progression of stage T1, grade 3 transitional cell carcinoma of the bladder following intravesical immunotherapy with bacillus Calmette-Guerin.
Brake M; Loertzer H; Horsch R; Keller H
J Urol; 2000 Jun; 163(6):1697-701. PubMed ID: 10799163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
